Diamedica Therapeutics Inc. · NASDAQ:DMAC
Richard Jacinto II reported a 9.60% stake in Diamedica Therapeutics Inc. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 7, 2025
Richard Jacinto II reported a 9.60% stake in Diamedica Therapeutics Inc., 4,958,823 shares, as a passive investor on Sep 30, 2025. Filed Nov 7, 2025 (Schedule 13G/A).
- Stake
- 9.60%
- Shares
- 4,958,823
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Richard Jacinto II | 9.60% | 4,958,823 |
Source
Related
- Diamedica Therapeutics Inc.
- Richard Jacinto II
- Diamedica Therapeutics Inc. shareholders
- Form 4 · Pauls Dietrich John · Aug 12, 2026
- Schedule 13G/A · John Fichthorn · Feb 17, 2026
- Schedule 13G/A · Cooperman Leon G · Feb 17, 2026
- Schedule 13G/A · Trill AB · Feb 6, 2026
- Schedule 13G/A · Cooperman Leon G · Oct 15, 2025